Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 682

  • Filters activated: AIDS. Clear all to show 2906 items.

Influence of male human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection on the reproductive outcomes in serodiscordant couples: a case-control study.

Cito G, Coccia ME, Fucci R, Picone R, Cocci A, Russo GI, Rizzello F, Trotta M, Badolato L, Basile V, Criscuoli L, Serni S, Carini M, Natali A.

Andrology. 2019 Apr 16. doi: 10.1111/andr.12623. [Epub ahead of print]


A New Generation of Drug Users in St. Petersburg, Russia? HIV, HCV, and Overdose Risks in a Mixed-Methods Pilot Study of Young Hard Drug Users.

Meylakhs P, Friedman SR, Meylakhs A, Mateu-Gelabert P, Ompad DC, Alieva A, Dmitrieva A.

AIDS Behav. 2019 Apr 11. doi: 10.1007/s10461-019-02489-6. [Epub ahead of print]


The interleukin 28B gene polymorphism, rs8099917, in patients with chronic hepatitis C and response to the treatment with pegylated interferon and ribavirin.

Kalantari H, Bagherpour B, Tavakoli T, Khodadoostan M, Hejazi SM, Saadatmand A.

J Res Med Sci. 2019 Feb 25;24:12. doi: 10.4103/jrms.JRMS_621_18. eCollection 2019.


Successful direct-acting antiviral therapy in HIV/HCV co-infected patients fails to restore circulating mucosal-associated invariant T cells.

Cannizzo ES, Cerrone M, Merlini E, van Wilgenburg B, Swadling L, Ancona G, De Bona A, d'Arminio Monforte A, Klenerman P, Marchetti G.

Eur J Immunol. 2019 Apr 15. doi: 10.1002/eji.201948152. [Epub ahead of print]


Hepatitis C virus infection in children and adolescents.

Indolfi G, Easterbrook P, Dusheiko G, El-Sayed MH, Jonas MM, Thorne C, Bulterys M, Siberry G, Walsh N, Chang MH, Meyers T, Giaquinto C, Wirth S, Chan PL, Penazzato M.

Lancet Gastroenterol Hepatol. 2019 Apr 10. pii: S2468-1253(19)30046-9. doi: 10.1016/S2468-1253(19)30046-9. [Epub ahead of print] Review.


The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy.

García F, Domínguez-Hernández R, Casado M, Macías J, Téllez F, Pascasio JM, Casado MÁ, Alados JC.

Enferm Infecc Microbiol Clin. 2019 Apr 11. pii: S0213-005X(19)30143-0. doi: 10.1016/j.eimc.2019.03.001. [Epub ahead of print] English, Spanish.


Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.

Bajis S, Grebely J, Cooper L, Smith J, Owen G, Chudleigh A, Hajarizadeh B, Martinello M, Adey S, Read P, Gilliver R, Applegate T, Treloar C, Maher L, Dore GJ; LiveRLife Study Group.

J Viral Hepat. 2019 Apr 13. doi: 10.1111/jvh.13112. [Epub ahead of print]


Quantifying the Risk of Undetected HIV, Hepatitis B Virus, or Hepatitis C Virus Infection in Public Health Service Increased Risk Donors.

Jones JM, Gurbaxani BM, Asher A, Sansom S, Annambhotla P, Moorman AC, Brooks JT, Basavaraju SV.

Am J Transplant. 2019 Apr 13. doi: 10.1111/ajt.15393. [Epub ahead of print]


Application of a Waveguide-Mode Sensor to Blood Testing for Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus and Treponema pallidum Infection.

Uno S, Shimizu T, Tanaka T, Ashiba H, Fujimaki M, Tanaka M, Awazu K, Makishima M.

Sensors (Basel). 2019 Apr 11;19(7). pii: E1729. doi: 10.3390/s19071729.


Hepatitis C Virus Treatment with Directly Acting Agents Reduces the Risk of Incident Diabetes - Results from ERCHIVES.

Butt AA, Yan P, Aslam S, Shaikh OS, Abou-Samra AB.

Clin Infect Dis. 2019 Apr 12. pii: ciz304. doi: 10.1093/cid/ciz304. [Epub ahead of print]


Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection.

Coppola N, Portunato F, Buonomo AR, Staiano L, Scotto R, Pinchera B, De Pascalis S, Amoruso DC, Martini S, Pisaturo M, Coppola C, Gentile I.

J Nephrol. 2019 Apr 11. doi: 10.1007/s40620-019-00608-z. [Epub ahead of print]


Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping.

Kao JH, Lin CY, Chuang WL, Cheng YY, Hu JY, Liang WK, Friebe P, Palmer S, Huang CS.

Diagn Microbiol Infect Dis. 2019 Mar 12. pii: S0732-8893(18)30453-X. doi: 10.1016/j.diagmicrobio.2019.02.020. [Epub ahead of print]


Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.

Scheibe A, Young K, Moses L, Basson RL, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, Manamela J, Puren AJ, Rebe K, Hausler H.

Harm Reduct J. 2019 Apr 11;16(1):28. doi: 10.1186/s12954-019-0298-2.


Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015.

Vaux S, Chevaliez S, Saboni L, Sauvage C, Sommen C, Barin F, Alexandre A, Jauffret-Roustide M, Lot F, Velter A; ANRS-Prevagay group.

BMC Infect Dis. 2019 Apr 11;19(1):315. doi: 10.1186/s12879-019-3945-z.


The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.

Crowley D, Lambert JS, Betts-Symonds G, Cullen W, Keevans M, Kelly E, Laird E, McHugh T, McKiernan S, Miggin SJ, Murphy C, Murtagh R, O'Reilly D, Tobin C, Van Hout MC.

Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800369.


Steatosis Rates by Liver Biopsy and Transient Elastography With Controlled Attenuation Parameter in Clinical Experience of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus/HCV Coinfection in a Large US Hepatitis Clinic.

Sansom SE, Martin J, Adeyemi O, Burke K, Winston C, Markham S, Go B, Huhn G.

Open Forum Infect Dis. 2019 Mar 1;6(4):ofz099. doi: 10.1093/ofid/ofz099. eCollection 2019 Apr.


Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting.

Overton K, Clegg J, Pekin F, Wood J, McGrath C, Lloyd A, Post JJ.

Int J Drug Policy. 2019 Apr 6. pii: S0955-3959(19)30078-7. doi: 10.1016/j.drugpo.2019.02.013. [Epub ahead of print]


Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.

Mouna L, Rossignol E, Tateo M, Coilly A, Duclos-Vallée JC, Duvoux C, Durand F, Tran A, Radenne S, Canva-Delcambre V, Houssel-Debry P, Dumortier J, Conti F, de Ledinghen V, Leroy V, Kamar N, Di Martino V, Moreno C, Botta Fridlund D, d'Alteroche L, Lebray P, Perre P, Besch C, Silvain C, Habersetzer F, Debette-Gratien M, Abergel A, Diallo A, Samuel D, Roque-Afonso AM, Pageaux GP; ANRS CO23 CUPILT study group.

J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30136-9. doi: 10.1016/j.jhep.2019.02.019. [Epub ahead of print] No abstract available.


Transmission Networks of HCV Genotype 1a Enriched With Pre-existing Polymorphism Q80K Among HIV-Infected Patients With Acute Hepatitis C in Poland: Erratum.

[No authors listed]

J Acquir Immune Defic Syndr. 2019 May 1;81(1):e27. doi: 10.1097/QAI.0000000000002034. No abstract available.


Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.

Beiser ME, Smith K, Ingemi M, Mulligan E, Baggett TP.

Int J Drug Policy. 2019 Apr 5. pii: S0955-3959(19)30079-9. doi: 10.1016/j.drugpo.2019.03.017. [Epub ahead of print]


Supplemental Content

Loading ...
Support Center